Jane Street
ADCT icon

Jane Street’s ADC Therapeutics ADCT Stock Holding History

Jane Street’s Portfolio ADCT Stock Details ADCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$47.6K Buy
+12,700
New +$50.1K ﹤0.01% 10986
2025
Q3 		– Sell
-14,500
Closed -$38.9K – 10667
2025
Q2 		$38.9K Buy
+14,500
New +$30.5K ﹤0.01% 9242
2024
Q2 		– Sell
-10,800
Closed -$48.5K – 9248
2024
Q1 		$48.5K Buy
+10,800
New +$39.8K ﹤0.01% 8748
2021
Q3 		– Sell
-16,000
Closed -$390K – 9834
2021
Q2 		$390K Buy
+16,000
New +$371K ﹤0.01% 7705

Other funds holding ADCT

RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Jane Street's ADCT Position: Q1 2026 in Review

Jane Street reduced its ADC Therapeutics (ADCT) stake by 29% in Q1 2026, selling an estimated $227K and leaving 142,063 shares worth $533K. The position accounts for ﹤0.01% of the portfolio, ranked #7904.

Jane Street first reported a position in ADCT in Q1 2023 and has held it in 9 quarters since. The position peaked at $1.95M in Q3 2025. 118 funds tracked by Wall St. Rank hold ADCT as of Q1 2026.

  • Jane Street held 142,063 shares of ADC Therapeutics worth $533K as of Q1 2026.
  • Jane Street sold 57,701 ADC Therapeutics shares in Q1 2026, an estimated $227K.
  • ADC Therapeutics made up ﹤0.01% of Jane Street's portfolio in Q1 2026, its #7904 holding.
  • Jane Street first reported a position in ADC Therapeutics in Q1 2023 and has held it in 9 quarters since.
  • Jane Street's ADC Therapeutics position peaked at $1.95M in Q3 2025.
  • 118 funds tracked by Wall St. Rank held ADC Therapeutics as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.